Nectar Lifescience Ltd :

17.96 -2.11 [-10.51%]

ISIN: INE023H01027 | NSE: NECLIFE | Industry: Pharmaceuticals - Indian - Bulk Drugs | BSE Code: 532649 | Comments

Price Information
• Open	20.55
• High	20.55
• Low	17.76
• Previous Close	20.07
• Shares Traded	141212
• 52 Wk High Price	23.90
• 52 Wk High Date	03-01-2013
• 52 Wk Low Price	13.40
• 52 Wk Low Date	05-04-2013
• Face Value	1.00

Fundamentals
• Market Capital (Rs.cr)	450.17
• EPS (Rs.)(TTM)	3.80
• P/E Ratio(TTM)	5.30
• Book Value (Rs.)	38.70
• Price to Book Value	0.52
• Equity (Rs.cr.)	22.43
• Traded Value (Rs.lac)	173.99

Corporate Actions
Ex-Date	Purpose (Rs.)
2011-09-21	10% Final Dividend (0.1)

Index Names
• BSE Small Cap

Related Companies
Stock Name	Price

DILLTD	453.00
GUJLYKAMERGE	15.65	-
GUJTHEMIS	12.22	-
JUBILANT	158.85
SHRISHMAFINE	0.42	-
REGENTCHEMICALS	2.00	-
CHEMDRUGSMERGE	440.00	-
CHEMOXCHEMICAL	1.10	-
ALPHADRUG	38.65	-
SEQUENTSCIENTIFIC	150.05

Share Tips for Nectar Lifescience Ltd

Buy Nectar Lifescience Ltd below 23.50 (01:46PM, Mar 09 '12)

Buy Nectar Lifescience Ltd above 23.50 (09:43AM, Aug 02 '11)

Buy Nectar Lifescience Ltd above 31.45 (03:13PM, Jan 05 '11)

Buy Nectar Lifescience Ltd above 31.45 (01:55PM, Jan 05 '11)

Buy Nectar Lifescience Ltd at 30.65, (02:14PM, Oct 26 '10)

Key Financials	Latest Qrtr.	Trailing Yr.	Full Yr.
• Year End	Mar, 2013	Mar, 2013	Mar, 2013
• Sales (Rs.cr)	367.64	1624.81	1624.81
• Net Profit (Rs.cr)	25.64	85.67	85.67
• Net Profit Var (%)	66.00	15.00	15.00
• EPS (Rs)	-	3.80	3.80
• P/E Ratio	-	5.30	5.30
• Operating Profit Margin	-	17.90	-
• CPS (Rs.)	-	-	7.20
• P/C Ratio	-	-	2.80
• Div%	-	-	10.00

Announcements
14-10-2011	NecLife gets European cGMP approved for its oral & injectables Cephalsporins API facility
07-05-2013	Nectar Lifesciences - Board to consider Final Dividend
09-09-2011	Nectar Lifesciences API facility gets USFDA approval
02-11-2012	Nectar Lifesciences appoints whole-time director
11-03-2011	Nectar Lifesciences receives approval from Japanese MOH
13-08-2011	Nectar Lifesciences recommends final dividend
01-08-2012	Nectar Lifesciences to consider final dividend

Gross Deliverables

Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover

17-05-2013 74887 141212 53.03 1344971 2612.02
13-05-2013 8000 8971 89.18 113520 128.00
11-05-2013 640 921 69.49 9312 13.43
10-05-2013 9423 12154 77.53 135691 174.86
03-05-2013 8264 13130 62.94 114291 183.18

Bulk Deals

Deal Date Client Name Type Qty Price

22-03-2013 YASH SHARES AND STOCK PVT LTD B 1573732 16.00
22-03-2013 CELLCAP INVOFIN INDIA PRIVATE LIMITED S 1200000 16.00
19-03-2013 SAURUBH BORA S 1443943 19.95

Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action

Comment(s) posted on Nectar Lifescience Ltd

Hot Searches • hospitals • bilpower • gitanja • talw • ambika • camlin • omaxe • renuka • crisil • icicibank

Date	Del. Shares	Trd. Qty.	Del.(%)	Del. Value	Turnover
17-05-2013	74887	141212	53.03	1344971	2612.02
13-05-2013	8000	8971	89.18	113520	128.00
11-05-2013	640	921	69.49	9312	13.43
10-05-2013	9423	12154	77.53	135691	174.86
03-05-2013	8264	13130	62.94	114291	183.18

Deal Date	Client Name	Type	Qty	Price
22-03-2013	YASH SHARES AND STOCK PVT LTD	B	1573732	16.00
22-03-2013	CELLCAP INVOFIN INDIA PRIVATE LIMITED	S	1200000	16.00
19-03-2013	SAURUBH BORA	S	1443943	19.95